Triple E for HCV: Treatment Expansion in High-Risk Communities: Engagement, Education and Eradication of HCV
This activity was developed for primary care physicians and health care professionals in the primary care field who manage patients with HCV and wish to improve standard practice care.
Jointly sponsored by The Annenberg Center for Health Sciences at Eisenhower and the Chronic Liver Disease Foundation.
This educational material was supported by an educational grant from AbbVie and Gilead.
Triple E for HCV: Engagement, Education, and Eradication of HCV Among Patients with Substance Use Disorders
Target Audience
This activity is targeted to physicians and other health care providers who
specialize in the management of patients with addictive disorders.
Educational Objectives
Upon completion of this activity, participants should be better able to:
•
Recognize the risks of exposure to HCV in injection drug users and identify epidemiologic trends of HCV infection in this population
•
Describe the natural history of chronic HCV infection
•
Demonstrate how proper HCV screening and diagnosis, as well as implementation of antiviral therapy, can improve long term outcomes in injection drug users
Accreditation Statement
Please see page 1 of the
newsletter for full
accreditation statement.
